Headquartered in Jinan, Shandong Dinghao Biotechnology Co., LTD. is a high-tech enterprise of around 200 employees, including more than 40 full-time R&D staff, engaged in the production, sale, and contract R&D of human and veterinary drug raw materials, pharmaceutical intermediates, and electronic chemicals. Its product lines span pharmaceutical intermediates for drugs including indapamide, osimertinib, upadacitinib, deucravacitinib, ruxolitinib, raltegravir, and buspirone; electronic materials such as VBC-series products, cyclopentanone, 2-adamantanone, and 6-bromonaphthalen-2-amine; and veterinary APIs including ceftiofur sodium, ceftiofur hydrochloride, ceftiofur free acid, cefquinome sulfate, cefaviacin sodium, decoquinate, gamithromycin, cephalonium, and tulathromycin. The company's 1,500 square meter R&D center, staffed by around 30 professionals including a doctorate holder and multiple masters-level researchers, supports synthesis reactions from 250 mL to 3,000 L scale. It offers CRO, CMO, and CDMO contract services along with OEM, ODM, and own-brand manufacturing, accepting T/T and L/C payment, and serves markets across North America, Latin America, Western and Eastern Europe, Asia, the Middle East, Africa, and Australasia.
No comments available.
Leave your rating & comment